Objective: To provide guidance for future randomized controlled trials (RCTs) based on a review concerning acupuncture for treating polycystic ovary syndrome (PCOS). Methods: A comprehensive literature search was conducted in October 2015 using MEDLINE, EMBASE, SCISEARCH, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Menstrual Disorders and Subfertility Group trials register, Allied and Complementary Medicine (AMED), China National Knowledge Infrastructure (CNKI), and the Wanfang databases. RCTs comparing either acupuncture with no/sham/pharmacological intervention or a combination of acupuncture and conventional therapy with conventional therapy in the treatment of PCOS were included in this review. A quality evaluation was performed for each of the included studies. Results: Thirty-one RCTs were included in the review and were divided into four categories according to the type of intervention used in the comparator or control group. Menstrual frequency, hormones, anthropometrics, insulin sensitivity, blood lipids, and fertility were used as the main measurements to assess the effects of acupuncture on the patients with PCOS. Thirty trials, except for one, showed an improvement in at least one of the indicators of PCOS after acupuncture treatment. However, normalizing the methodological and reporting format remains an issue. Conclusions: Based upon this review of current clinical trials concerning acupuncture for treating PCOS, we provide guidelines for better clinical trial design in the future.
Introduction
Polycystic ovary syndrome (PCOS), a complex genetic disorder, is a significant women's health issue, which shows an increasing annual prevalence (Franks, 1995; Ehrmann, 2005; Stefanaki et al., 2015) . It is characterized by the presence of polycystic ovaries, chronic oligo/anovulation, hyperandrogenism, infertility, hyperinsulinemia, insulin resistance, and obesity (Norman et al., 2007) . Patients with PCOS often need pharmacological treatment for a long period of time. First-line therapy for PCOS is oral contraceptives, which can effectively alleviate hirsutism and acne; however, these may adversely affect glucose tolerance, coagulability, and fertility (Lanham et al., 2006) . Acupuncture has been used to treat gynecological disorders for thousands of years (Zhou and Qu, 2009) . It is sometimes chosen by women with PCOS as an alternative therapy or used as an adjunct while undergoing infertility treatment (Stener-Victorin et al., 2008) . Previous studies have shown that acupuncture can effectively treat PCOS by: (1) modulating the sympathetic outflow through spinal reflexes; (2) affecting the hypothalamic pituitary adrenocortical (HPA) and hypothalamic pituitary ovarian (HPO) axes by increasing central β-endorphin (Johansson and Stener-Victorin, 2013) . Over 50 studies have been conducted to explore the effects of acupuncture on PCOS (Stener-Victorin et al., 2008; Zheng et al., 2012) . The aim of this review is to provide guidance to augment the accuracy of future randomized controlled trials (RCTs) relating to acupuncture for treating PCOS.
Methods
A review of the existing RCTs on acupuncture for the treatment of women with PCOS was performed through a systematic literature search using the following databases: MEDLINE (1966 to October 2015 , EMBASE (1974 to October 2015 , SCISEARCH (1974 to October 2015 , Cumulative Index to Nursing and Allied Health Literature (1982 to October 2015) , the Cochrane Menstrual Disorders and Subfertility Group trials register (October 2015) , Allied and Complementary Medicine (AMED) (1985 ( to October 2015 , China National Knowledge Infrastructure (CNKI) (1982 ( to October 2015 , and the Wanfang database (1982 ( to October 2015 . The reference lists of relevant primary and review articles were also checked to identify further published trials not uncovered in the database search. There were no restrictions placed on language or publication type in the searches.
Search terms and key words included: "polycystic ovary morphology" or "polycystic ovary syndrome" or "polycystic ovary" or "ovary polycystic disease" or "PCOS" or "oligo-amenorrhea" or "oligoamenorrhea" or "oligoanovulatory" or "oligohypomenorrhea" or "amenorrhea" or "amenorrhoea" or "hirsutism" AND "acupoint" or "acupressure" or "acupressure-acupuncture therapy" or "acupuncture" or "electro-acupuncture" or "electroacupuncture" or "moxibustion" or "Tui Na" or " traditional medicine" or "traditional Chinese medicine" or "traditional Chinese medicine combined with western medicine." All search terms were translated into Chinese terms in order to conduct the searches in Chinese databases.
PCOS was diagnosed according to the European Society for Human Reproduction and Embryology (ESHRE) and American Society for Reproductive Medicine (ASRM) (The Rotterdam ESHRE/ASRMSponsored PCOS Consensus Workshop Group, 2004). "Acupuncture" was defined as traditional needling acupuncture, auricular acupuncture, electro-acupuncture (EA), auricular acupressure, and warm needling acupuncture. RCTs belonging to one of the following categories were included: (1) acupuncture vs. sham/no intervention; (2) acupuncture+conventional therapy vs. conventional therapy; (3) acupuncture vs. conventional therapy; (4) two or more of the above situations. "Conventional therapy" involved pharmacotherapy for ovulation induction, ethinylestradiol and cyproterone acetate tablets (ECAT), metformin, and Chinese medicinal herbs (CMH). Case reports, reviews, animal experiments, self-control clinical studies, and studies with acupuncture in the control group were excluded.
Study selection and data extraction were performed by two authors (FQ and YW) independently, and disagreements were resolved by discussion. Data abstracted from the accepted RCTs included: details of the participants, countries, interventions, outcomes, ethical/institutional review board approval, randomization, single/multi-center, concealment of allocation, blinding, comparability at the baseline, sample size calculation, adverse effects, follow-up and background information about the acupuncture practitioner, which are based upon adherence to the Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) (MacPherson et al., 2010) .
Results

Main study characteristics
A total of 31 RCTs that included 2371 women with PCOS met our inclusion criteria (Yang et al., 2005; Zhao et al., 2007; Shi et al., 2009; StenerVictorin et al., 2009; Lai et al., 2010; Li and Han, 2010; Cui W. et al., 2011; Jedel et al., 2011; Li and Zhang, 2011; Li Y.L. et al., 2011; Pastore et al., 2011; Cui Y. et al., 2012; Franasiak et al., 2012; Liu et al., 2012; Li, 2013; Liang et al., 2013a; 2013b; Rashidi et al., 2013; Wang and Gu, 2013; Wang and Li, 2013; Zhang, 2013; Zheng et al., 2013; He, 2014; Jin et al., 2014; Leonhardt et al., 2014; Li L. et al., 2014; Lin, 2014; Liang, 2015a; 2015b; Qiu et al., 2015; Sheng, 2015; Wang, 2015) . A short description of the studies included in this review was shown in Table 1 . Of the 31 included trials, three were performed in Sweden (Stener-Victorin et al., 2009; Jedel et al., 2011; Leonhardt et al., 2014) , one in the USA (Pastore et al., 2011; Franasiak et al., 2012) , one in Iran (Rashidi et al., 2013) , and all other trials were conducted in China. After the studies were divided into four categories according to interventions, five were identified as "acupuncture vs. sham/no intervention," fifteen as "acupuncture+conventional therapy vs. conventional therapy," nine as "acupuncture vs. conventional therapy," and two as "comparison between different groups containing two or more of the above situations."
Study quality of the trials
All of the included 31 RCTs were single-center trials. The average number of patients with PCOS was 75, with a range of 20 to 217. In this review, menstrual frequency, hormones, anthropometrics, insulin sensitivity, blood lipids, and fertility were used as the main measurements to assess the effects of acupuncture in treating PCOS. Menstrual frequency and hormones (follicle stimulating hormone (FSH), luteotropic hormone (LH), LH/FSH, and testosterone (T)) were the most common measurements used in evaluating the effect of a therapy on PCOS, and they were available in 25 of the 31 included trials (Zhao et al., 2007; Shi et al., 2009; Stener-Victorin et al., 2009; Lai et al., 2010; Li and Han, 2010; Jedel et al., 2011; Li and Zhang, 2011; Li Y.L. et al., 2011; Pastore et al., 2011; Cui Y. et al., 2012; Franasiak et al., 2012; Liu et al., 2012; Liang et al., 2013a; 2013b; Wang and Gu, 2013; Wang and Li, 2013; Zhang, 2013; Zheng et al., 2013; He, 2014; Jin et al., 2014; Leonhardt et al., 2014; Li L. et al., 2014; Lin, 2014; Liang, 2015a; 2015b; Qiu et al., 2015; Wang, 2015) . Anthropometric measurements, such as body weight, body mass index (BMI), waist, waist-hip ratio (WHR), and the FerrimanGallwey score were available in 10 of the 31 included trials (Zhao et al., 2007; Stener-Victorin et al., 2009; Lai et al., 2010; Jedel et al., 2011; Liu et al., 2012; Zheng et al., 2013; Jin et al., 2014; Leonhardt et al., 2014; Liang, 2015a; 2015b) . Measurements about insulin sensitivity including fasting insulin (FINS), fasting plasma glucose (FPG), and homeostasis model assessment for insulin resistance (HOMA-IR) were available in 9 of the 31 trials (Zhao et al., 2007; Stener-Victorin et al., 2009; Lai et al., 2010; Jedel et al., 2011; Liu et al., 2012; Zheng et al., 2013; Leonhardt et al., 2014; Liang, 2015a; 2015b) . Measurements about blood lipids including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were available only in four trials (Lai et al., 2010; Jedel et al., 2011; Stener-Victorin et al., 2012; Zheng et al., 2013; Leonhardt et al., 2014) . Only nine trials that used acupuncture in treating infertile women with PCOS had measured ovulation rate (OR), clinical pregnancy rate (CPR), and miscarriage rate (MR) (Yang et al., 2005; Cui W. et al., 2011; Li, 2013; Rashidi et al., 2013; Wang and Gu, 2013; Qiu et al., 2015; Sheng, 2015; Wang, 2015) . More outcomes used in the included trials are shown in Table 1 . Acupuncture was used alone in 14 trials (Yang et al., 2005; Stener-Victorin et al., 2009; Lai et al., 2010; Jedel et al., 2011; Li and Zhang, 2011; Pastore et al., 2011; Cui Y. et al., 2012; Franasiak et al., 2012; Li, 2013; Rashidi et al., 2013; Wang and Li, 2013; Zheng et al., 2013; He, 2014; Jin et al., 2014; Leonhardt et al., 2014) , and along with pharmacotherapy for ovulation induction, CMH, ECAT or metformin in the other 17 trials. Among the 31 trials reviewed, blinding was only applied in three RCTs (Stener-Victorin et al., 2009; Pastore et al., 2011; Franasiak et al., 2012; . In one trial, researchers failed to find significant differences in the outcomes between true and sham acupuncture (control) (Pastore et al., 2011; Franasiak et al., 2012) . In the other 30 trials, there was an improvement in at least one of the indicators of PCOS after acupuncture treatment, when compared with the control group. 
Reporting quality
As shown in Table 2 , the reporting quality was evaluated for each of the 31 studies included. In the review, 18 trials (Shi et al., 2009; Stener-Victorin et al., 2009; Lai et al., 2010; Li and Han, 2010; Cui W. et al., 2011; Jedel et al., 2011; Li and Zhang, 2011; Pastore et al., 2011; Franasiak et al., 2012; Li, 2013; Rashidi et al., 2013; Wang and Gu, 2013; Zheng et al., 2013; Leonhardt et al., 2014; Li et al., 2014; Liang, 2015a; 2015b; Sheng, 2015) described the method of randomization; however, 5 of them were not fully randomized as the sequence was generated by registration order (Lai et al., 2010; Li and Han, 2010; Wang and Gu, 2013; Li et al., 2014; Liang, 2015a) . Six trials had adequate concealment of allocation (Stener-Victorin et al., 2009; Jedel et al., 2011; Pastore et al., 2011; Franasiak et al., 2012; Rashidi et al., 2013; Zheng et al., 2013; Leonhardt et al., 2014) . In the present review, only eight trials included information regarding ethical/institutional review board approval (Stener-Victorin et al., 2009; Lai et al., 2010; Jedel et al., 2011; Pastore et al., 2011; Franasiak et al., 2012; Rashidi et al., 2013; Zheng et al., 2013; Leonhardt et al., 2014; Sheng, 2015) . Four trials provided a power analysis and presented a sample size calculation (Jedel et al., 2011; Pastore et al., 2011; Franasiak et al., 2012; Stener-Victorin et al., 2012; Rashidi et al., 2013; Leonhardt et al., 2014) . In addition, we found only six trails adhered to STRICTA and reported the acupuncture practitioners (StenerVictorin et al., 2009; Jedel et al., 2011; Pastore et al., 2011; Franasiak et al., 2012; Rashidi et al., 2013; Zheng et al., 2013; Leonhardt et al., 2014) . Seven trials in the review provided information regarding adverse effects during the research period (Yang et al., 2005; Lai et al., 2010; Jedel et al., 2011; Stener-Victorin et al., 2012; Li, 2013; Zheng et al., 2013; Leonhardt et al., 2014; Li et al., 2014; Liang, 2015b) and four trials described the follow-up information (Jedel et al., 2011; Pastore et al., 2011; Franasiak et al., 2012; Stener-Victorin et al., 2012; Wang and Li, 2013; Zhang, 2013; Leonhardt et al., 2014) .
Discussion
About study quality
While single-center trials are excellent for investigating research hypotheses, they also have inherent limitations. In contrast, multi-center trials expand the statistical power, increase generalizability, and moderately affect the sizes to maximize overall robustness. It would be advantageous to conduct more multi-center trials in the future to confirm the generalizability of the interventions.
For clinical trials, outcome measurements, whether objective, subjective, or patient-centered, should be disease-specific and follow the international classification of diseases. In this review, a range of objective, subjective, and patient-centered outcome measurements was identified in the included RCTs. Menstrual frequency, ovulation, CPR, and hormones were the most common measurements used in the included trials, and no other measurements were used to assess the effects of acupuncture on patients with PCOS in the several trials. Due to the various clinical manifestations of PCOS, measurements of anthropometry, insulin sensitivity, and blood lipids should be more frequently used. Patient-centered outcome measurements, such as questionnaire scores of life quality among patients with PCOS, should be used in conjunction with conventional measurements.
According to the interventions and controls, the included studies were divided into four categories as mentioned above. Among these, "acupuncture vs. sham acupuncture" might be the best design to evaluate the effectiveness of acupuncture on PCOS, as it can eliminate the placebo effects of acupuncture.
For an acupuncture treatment, it may be difficult to obtain "ideal" blinding, especially for subjects who have received prior acupuncture. In an RCT that investigates the effects of acupuncture in treating PCOS, blinding should be evaluated at the beginning of the trial to minimize placebo and expectancy effects of acupuncture from verbal and non-verbal communications with enrolled subjects. For an RCT of acupuncture, it may be difficult to find an ideal placebocontrol method (Vincent and Lewith, 1995; Margolin et al., 1998; Tang et al., 1999; Emanuel and Miller, 2001; Sherman et al., 2004) . For non-drug interventions including acupuncture, it has been difficult to establish a placebo or sham control that is both inert and indistinguishable (Dincer and Linde, 2003) . A baseline measurement of the effectiveness of acupuncture in treating PCOS is helpful in determining whether the active acupuncture intervention is superior or equivalent to the placebo-controls. The selection of acupoints and the visual impact of needling are all key factors that can affect the "placebo" response.
About reporting quality
An important factor in any RCT is randomization. This ensures that the baseline factors of each group are equally distributed. Detailed information on randomization should be provided in future RCTs.
As delivery, frequency, and intensity of acupuncture treatment may influence outcomes, such details should be recorded, including the number of needle insertions per subject per session (mean and range where relevant), names (or location if no standard name) of acupoints used (uni/bilateral), depth of insertion based on a specified unit of measurement or on a particular tissue level, response sought (e.g. de qi or muscle twitch response), needle stimulation (e.g. manual, electrical), needle retention time, needle type (diameter, length, and manufacturer or material), number of treatment sessions, frequency and duration of treatment sessions, and details of other interventions administered to the acupuncture group (e.g. moxibustion, cupping, herbs, exercises, lifestyle advice) (MacPherson et al., 2010) . A minimum of four acupuncture treatment sessions is recommended to obtain satisfactory curative effects when treating PCOS women. These details should be described in future RCTs concerning acupuncture for treating PCOS.
For all clinical trials, it is important to obtain ethical/institutional review board approval before initiation. The ethical considerations of the acupuncture trials should be described in detail, including the approval of an institutional review board and date of approval.
The sample size of RCTs concerning acupuncture should be calculated a priori based upon previous studies. Insufficient sample size will definitely lead to weakening of the statistical characteristics. To effectively calculate the adequate sample size, it is important to perform and describe an appropriate power calculation, an estimate of drop-out rates and to establish a practical recruitment strategy concerning how patients will be approached and recruited into the trial.
STRICTA, a series of guidelines to provide authors a way to structure their reports of acupuncture interventions with a minimum set of items using a checklist, not only facilitates transparency in published reports, but also describes all the necessary details to replicate the trials. The revised STRICTA guideline includes 6 items and 17 sub-items, which set the reporting guidelines for the acupuncture rationale, the details of needling, the treatment regimen, other components of treatment, the practitioner background, and the control or comparator intervention (MacPherson et al., 2010) . It seems that STRICTA had not yet been taken into account in most of the studies on acupuncture for PCOS. We strongly recommend that STRICTA should be used as the gold standard in designing and reporting the protocol for acupuncture in clinical trials.
The preferences and expectation of patients may be contributing factors in the effectiveness of acupuncture. Since high expectations for acupuncture may correlate with high response rates and improved outcomes in the placebo control group, it may be difficult to detect a significant difference between the active acupuncture and placebo control interventions. To address this, a run-in phase stratification for randomization and measurements of expectation should be used in RCTs involving acupuncture. A simple and effective tool to evaluate expectations at baseline is to ask questions such as: "How effective do you consider acupuncture to be in general?" with responses that include "very effective, effective, slightly effective, not effective, do not know." As the experience, expectations and knowledge of acupuncture among patients with PCOS in various countries may influence the effectiveness of acupuncture on PCOS, such information should be taken into consideration and described.
For an RCT, safety is of utmost importance. The patients should be instructed to record the time of acupuncture treatment and any adverse effects in a diary. More attention should be paid to adverse effects in the future studies concerning acupuncture for treating PCOS.
Although traditional Chinese medicine and acupuncture may have a more gradual time course of effectiveness than pharmacotherapy, these may also provide longer-term and sustained health benefits to patients with PCOS. Consequently, it is necessary to include information related to the follow-up periods that are long enough (at least one year after cessation of treatment) to optimally evaluate the effectiveness of acupuncture in treating patients with PCOS. A long period of follow-up should be performed and described in future trials.
As the needling stimulation in traditional Chinese acupuncture is invasive and can be painful, it may lead to higher drop-out rates than non-invasive treatments. Transcutaneous acupoint electrical stimulation (TEAS), a non-invasive acupuncture, may be effective (Zhang R. et al., 2011; Zhang Q. et al., 2014) . For patients with PCOS who are not willing to receive invasive treatment, TEAS may be a more suitable intervention, which is a new development for traditional acupuncture under the advancement of modern science (Zhang R. et al., 2011; Zhang Q. et al., 2014) .
Based on review of the evidences for acupuncture treatment for PCOS, we highlighted how future trials can be improved and where efforts should now be focused to improve the evidence base. However, some of these may be a little limited, due to the complexity of this disease, PCOS, and the marked differences on the design of the included trials.
